Fertility Preservation for Female Cancer Patients: What You Need to Know

A cancer diagnosis brings with it a whirlwind of decisions, emotions, and uncertainties. For many, one of the major concerns is how treatment may impact their ability to have children in the future. With advancements in cancer therapies, survival rates continue to improve, but the reality is that specific treatments—like chemotherapy and radiation—can have long-lasting effects on fertility. This is where fertility preservation becomes crucial.

Fertility preservation for cancer patients offers hope, allowing individuals to safeguard their reproductive potential before starting life-saving treatments. Whether you’re newly diagnosed or supporting a loved one facing this challenge, understanding your options for fertility preservation can be an empowering step in planning for the future.

Let’s explore the different fertility preservation methods available to cancer patients, the timing and steps involved, and how working with a specialized clinic like NCCRM can provide personalized care throughout your journey. By the end, you’ll have a comprehensive understanding of preserving fertility during this critical time, giving you peace of mind for the future.

What is fertility preservation?

Fertility preservation is a proactive approach to safeguarding an individual’s ability to have biological children in the future. For cancer patients, this means taking specific measures before undergoing treatments that could harm reproductive organs or reduce fertility. Cancer therapies such as chemotherapy, radiation, and certain surgeries are often necessary to fight the disease. Still, they can come with the unfortunate side effect of affecting a patient’s ability to conceive later in life.

In simple terms, fertility preservation allows cancer patients to freeze and store reproductive materials—like eggs, sperm, embryos, or ovarian tissue—so the reproductive tissues can be used at a later time when the patient is ready to pursue parenthood. Fertility preservation can be crucial for young adults or adolescents diagnosed with cancer who may not yet have had the chance to start their families.

Why It Matters for Cancer Patients

Many cancer treatments, while vital for survival, can cause temporary or permanent damage to reproductive cells and organs. For women, treatments may deplete egg reserves or damage the ovaries. For men, they can affect sperm production or damage the testes. By taking steps to preserve fertility before treatment begins, patients can have a backup plan for future family-building, even if their fertility is compromised during cancer treatment.

Timing Is Critical

One of the most critical factors in fertility preservation is timing. Because fertility preservation procedures typically need to be done before cancer treatment begins, cancer patients are advised to consult with a fertility specialist as soon as possible after diagnosis. Delaying can reduce the chances of successful preservation and increase the risks of infertility later on. This is why having a dedicated fertility team, like NCCRM, to work alongside the oncology team is crucial in helping patients make timely, informed decisions.

How Cancer Treatments Impact Female Fertility

Cancer treatments like chemotherapy, radiation, and certain surgeries are designed to attack cancer cells, but they can also damage healthy cells, including those in the reproductive system. For many cancer patients, especially younger individuals, the possibility of infertility becomes a significant concern. Understanding how these treatments impact fertility can help patients make informed decisions about preserving their reproductive future.

Chemotherapy and Its Effects on Fertility

Chemotherapy is a standard treatment for many types of cancer, and it works by targeting rapidly dividing cells, which include cancer cells. Unfortunately, reproductive cells—eggs in women —are also rapidly dividing, making them vulnerable to chemotherapy’s effects.

Chemotherapy can damage the ovaries, reducing the number of healthy eggs, which can lead to temporary or permanent infertility, depending on the type of chemotherapy, the dosage, and the woman’s age at the time of treatment. Younger women generally have more eggs and may have a better chance of retaining fertility after treatment, but there are no guarantees. Chemotherapy may also bring on early menopause, further complicating fertility outcomes.

Radiation Therapy and Fertility

Radiation therapy uses high-energy rays to kill cancer cells in specific body areas. The impact of radiation on fertility depends mainly on the part of the body being treated and the radiation dosage. If radiation is directed at or near the pelvis, it can harm the ovaries, fallopian tubes, uterus, and other reproductive organs. This damage can result in reduced ovarian function or premature ovarian failure, where the ovaries stop working earlier than expected. Radiation can also affect the lining of the uterus, making it difficult for a woman to carry a pregnancy to term. Protective techniques may reduce some risks, such as ovarian shielding or moving the ovaries out of the radiation field (called ovarian transposition).

Surgery and Its Impact on Fertility

In some cases, surgery is necessary to remove cancerous tissue or tumors, but this can sometimes involve the removal of reproductive organs, leading to permanent infertility.

If a woman undergoes surgery to remove her ovaries (oophorectomy) or uterus (hysterectomy), her ability to conceive naturally will be affected. Depending on the type of cancer and its location, some surgeries may preserve fertility, but it’s crucial to have these conversations with both the oncologist and a fertility specialist.

Hormonal Therapies and Fertility

In addition to chemotherapy, radiation, and surgery, some cancer treatments involve the use of hormonal therapies, especially in cancers like breast or prostate cancer, which are hormone-sensitive. These therapies can disrupt average hormone production, which is necessary for reproductive health and function. Hormonal therapies may suppress ovarian function, preventing ovulation and reducing fertility during and sometimes after treatment. For some women, regular reproductive function returns after therapy, while others may experience long-term effects.

Understanding the Risks Early Is Key

Cancer patients should understand that fertility may not be their first concern when facing a life-threatening illness, but knowing the risks cancer treatments pose to reproductive health is essential for those who wish to have biological children in the future. By addressing these risks early, patients can explore fertility preservation options like egg or sperm freezing before starting treatment.

Each cancer patient’s journey is unique, and fertility risks vary depending on the type of cancer, treatment plan, and personal circumstances. Consulting with a fertility specialist, such as the team at NCCRM, can help patients weigh their options and take proactive steps toward preserving their fertility during a challenging time.

Fertility Preservation Options for Women

For women diagnosed with cancer, the prospect of undergoing treatments that could harm their fertility can be distressing. Fortunately, there are several fertility preservation options available that can offer hope for future family-building. These techniques allow women to store eggs, embryos, or ovarian tissue before starting cancer treatment, ensuring that they have the potential to conceive after their recovery.

Egg Freezing (Oocyte Cryopreservation)

Egg freezing, also known as oocyte cryopreservation, is one of the most well-established fertility preservation methods for women. It involves stimulating the ovaries to produce multiple eggs, which are retrieved and frozen for future use.

  • Process: The process begins with ovarian stimulation using hormones to encourage the production of multiple eggs throughout about 10 to 14 days. Once the eggs are mature, they are retrieved in a minor surgical procedure. The eggs are then frozen and stored until the patient is ready to use them, potentially years after cancer treatment.
  • Success Rates: The success of egg freezing depends on the woman’s age and the number of viable eggs retrieved. Younger women generally have better success rates and tend to have healthier eggs. Once the eggs are thawed, they can be fertilized with sperm to create embryos for implantation.
  • Timing: Since ovarian stimulation takes about two weeks, it’s critical to consult with a fertility specialist as soon as possible after a cancer diagnosis. This allows time for the egg retrieval process before starting cancer treatments, which can damage egg quality or quantity.

Embryo Freezing

Embryo freezing is similar to egg freezing but with one crucial difference: the eggs are fertilized with sperm before freezing, creating embryos that can be implanted later. This is a good option for women who have a partner or are open to using donor sperm.

  • Process: As with egg freezing, ovarian stimulation is required to produce multiple eggs. After retrieval, the eggs are fertilized with sperm in the lab to create embryos. These embryos are then frozen and stored until the woman is ready to try for a pregnancy.
  • Success Rates: Embryo freezing generally has a higher success rate than egg freezing, as embryos are more resilient during the freezing and thawing. Women who choose this option have better chances of achieving pregnancy later.
  • Considerations: Embryo freezing is an ideal option for women who are confident about their choice of sperm donor (whether a partner or anonymous donor) and are comfortable with having embryos stored. The decision to freeze embryos is more complex because of the ethical and legal implications of handling embryos compared to eggs.

Ovarian Tissue Freezing

Ovarian tissue freezing is an experimental yet promising option for fertility preservation, particularly for young girls or women who cannot undergo ovarian stimulation before cancer treatment. This technique involves surgically removing and freezing a portion of ovarian tissue that contains eggs. NCCRM does not offer ovarian tissue freezing. However, it is essential to gain knowledge of all potential options available. 

  • Process: A surgeon removes part or all of one ovary through a minimally invasive procedure. The tissue is then frozen and stored. After cancer treatment, the tissue can be transplanted back into the woman’s body, where it may resume normal hormone production and egg release, allowing for natural conception.
  • Success Rates: While still experimental, ovarian tissue freezing has resulted in successful pregnancies. The procedure is typically offered to women who cannot delay cancer treatment long enough for egg or embryo freezing.
  • Advantages: Ovarian tissue freezing may be the only option for young girls who haven’t yet reached puberty, as they cannot undergo ovarian stimulation. It also allows for the possibility of natural conception without IVF, as the transplanted tissue can restore ovarian function.

Other Fertility Preservation Techniques

While egg, embryo, and ovarian tissue freezing are the most common fertility preservation methods for women, there are a few additional techniques worth noting:

  • Ovarian Suppression: In some cases, medications called gonadotropin-releasing hormone (GnRH) agonists can be used during chemotherapy to suppress ovarian function temporarily. By putting the ovaries in a “resting” state, these medications may help protect the eggs from damage. However, this method is less reliable than freezing eggs or embryos and is typically used in conjunction with other fertility preservation techniques.
  • Protective Shielding During Radiation: Special techniques can shield the ovaries from radiation exposure for women undergoing radiation therapy near the pelvic region. In some cases, surgeons may also move the ovaries out of the radiation field—a procedure known as ovarian transposition—to minimize damage.

Factors to Consider When Choosing a Method

When deciding on a fertility preservation option, several factors come into play:

  • Age: Younger women tend to have more viable eggs and may have higher success rates with fertility preservation.
  • Cancer Type and Treatment Plan: The type of cancer and the aggressiveness of the treatment plan may limit the time available for fertility preservation. Certain treatments may also affect which methods are safest.
  • Time Constraints: Some preservation methods, like egg or embryo freezing, require at least two weeks for ovarian stimulation. If cancer treatment must begin immediately, other options like ovarian tissue freezing or ovarian suppression may be considered.

Each woman’s situation is unique, and a personalized consultation with a fertility specialist is crucial to determining the best preservation method based on medical, emotional, and logistical factors.

For women diagnosed with cancer, the dream of having children doesn’t have to end with treatment. Advances in fertility preservation techniques offer hope and allow for planning beyond the immediate challenge of cancer. At NCCRM, our team is dedicated to helping cancer patients navigate these options with care and expertise, ensuring that every woman has the opportunity to explore her fertility preservation choices before treatment begins.

Success Rates and Considerations

When it comes to fertility preservation for cancer patients, understanding the success rates and factors that can influence the outcomes is crucial. While fertility preservation offers hope for future family-building, the success of each method depends on several variables, including the type of preservation technique, the patient’s age, and the specific cancer treatment being received. Here, we’ll explore the general success rates of various fertility preservation methods and the key considerations cancer patients should consider.

Success Rates of Fertility Preservation Methods

The success rates of fertility preservation methods can vary widely depending on several factors, including the patient’s age, the quality of the eggs or sperm, and how well the reproductive cells survive freezing and thawing.

  • Egg Freezing: Egg freezing success rates largely depend on the woman’s age at the time of freezing. The younger a woman is when she freezes her eggs, the higher the chances of a successful future pregnancy. In general, for women under 35, about 90-95% of eggs survive the freezing and thawing process, and the pregnancy success rates from thawed eggs are similar to those from fresh eggs, at around 40-50%. For women over 35, success rates tend to decline as the quality and quantity of eggs decrease with age.
  • Embryo Freezing: Embryo freezing tends to have slightly higher success rates than egg freezing, primarily because embryos are more resilient during freezing and thawing. Success rates can range from 50% to 60% per embryo transfer, depending on the woman’s age, the quality of the embryos, and other factors. Embryos created from younger eggs typically have higher success rates.
  • Ovarian Tissue Freezing: This is still considered an experimental technique, but it has sometimes resulted in successful pregnancies. The success rates for ovarian tissue freezing are not as well established as those for egg or embryo freezing. However, studies suggest that ovarian tissue transplantation can restore ovarian function in about 60-70% of cases, with a lower percentage leading to successful pregnancies. The technology is continually improving, giving hope to women who cannot undergo traditional fertility preservation methods.

Factors Affecting Success Rates

Age of the Patient

Age is one of the most significant factors in determining the success of fertility preservation methods. For women, the quality and quantity of eggs decline with age, which affects both the success of egg or embryo freezing and the chances of a successful pregnancy later on. Women under 35 generally have a much higher chance of achieving pregnancy with frozen eggs or embryos than women over 35, whose eggs may be fewer in number and of lower quality. Men’s sperm quality also declines with age, though not as dramatically as egg quality in women.

Type of Cancer and Treatment

The type of cancer and the treatment being used can also affect fertility and preservation success. Some cancers, such as those affecting the reproductive organs (e.g., ovarian, testicular, or prostate cancers), may pose a greater risk to fertility. Additionally, more aggressive cancer treatments, such as high doses of chemotherapy or radiation to the pelvic area, are more likely to cause permanent damage to reproductive cells.

Patients with less aggressive cancers or those receiving targeted therapies may have a better chance of maintaining fertility or recovering it after treatment. However, regardless of the cancer type, early intervention and consultation with a fertility specialist are critical to maximizing the chances of successful fertility preservation.

Quality and Quantity of Eggs

The quality and quantity of the preserved reproductive cells are key factors in determining success. Women who produce more eggs during ovarian stimulation will generally have more opportunities to achieve pregnancy. Poor-quality eggs may reduce the chances of successful fertilization or embryo implantation.

Timing of Fertility Preservation

Timing is everything when it comes to fertility preservation. Ideally, patients should undergo fertility preservation before starting cancer treatment, as chemotherapy and radiation can cause irreversible damage to eggs or ovarian tissue. In cases where cancer treatment must begin immediately, fertility specialists may explore options such as ovarian tissue freezing for women or testicular tissue extraction for men.

The sooner a patient consults with a fertility specialist after diagnosis, the better the chances of preserving healthy reproductive material. Patients should also be aware that ovarian stimulation (for egg or embryo freezing) takes about two weeks, so it’s important to begin the process as early as possible.

Emotional Considerations

Fertility preservation is not just a physical process; it can also carry a significant emotional burden. Facing cancer and the possibility of infertility can be overwhelming, and patients may experience anxiety or sadness about their future family-building potential. Patients need to seek emotional support during this time, whether from counselors, support groups, or loved ones.

At NCCRM, we understand the emotional toll that cancer and fertility preservation can take on patients. Our team offers compassionate care and support to help patients navigate their options and feel empowered throughout the fertility preservation process.

Fertility preservation offers hope for cancer patients who wish to have biological children in the future, but understanding the factors that affect success rates is essential. By working with a fertility specialist and exploring the available options, patients can take proactive steps to safeguard their reproductive future, ensuring that the dream of parenthood remains within reach after cancer treatment.

When to Consider Fertility Preservation

Deciding when to consider fertility preservation is a crucial part of cancer treatment planning for patients who hope to have biological children in the future. Cancer treatments such as chemotherapy, radiation, and surgery can negatively impact fertility, so patients need to be proactive in assessing their options. Fertility preservation is most effective when planned early, ideally before treatment begins. 

Before Starting Cancer Treatment

The best time to consider fertility preservation is immediately after a cancer diagnosis, before starting any treatments that may harm reproductive health. Fertility preservation techniques, such as egg or sperm freezing, are most effective when reproductive cells are harvested before chemotherapy, radiation, or surgery. Once these treatments begin, the chances of successfully preserving fertility diminish, as cancer therapies can damage eggs, sperm, and reproductive tissues.

  • Why Timing Matters: Many cancer treatments, especially chemotherapy and radiation, are highly toxic to the ovaries and testes. These treatments can deplete a woman’s egg supply or reduce sperm production in men, leading to infertility. Early intervention allows for the collection of healthy eggs or sperm before cancer therapy causes any damage.
  • How Early Is Early Enough? Fertility preservation is ideally completed as soon as possible after a diagnosis. This provides enough time for procedures like ovarian stimulation, egg retrieval, or sperm collection, which may take several days to two weeks to complete. Even if cancer treatment needs to start quickly, some fertility preservation methods, like sperm freezing or testicular tissue extraction, can be done rapidly with minimal delay.

Key Considerations

For women, fertility preservation should be considered as soon as a cancer diagnosis is made, especially for those who plan to undergo chemotherapy, pelvic radiation, or surgical procedures that affect the reproductive organs.

  • Before Chemotherapy or Radiation: Chemotherapy drugs, especially those used to treat cancers such as lymphoma, leukemia, and breast cancer, can severely reduce the number of viable eggs a woman has. Radiation to the pelvic area can also cause significant damage to the ovaries and uterus, increasing the risk of infertility or early menopause. Women should consult a fertility specialist before beginning these treatments to explore options like egg or embryo freezing.
  • Before Surgery Involving the Reproductive Organs: Some cancers may require surgical removal of reproductive organs, such as the ovaries, uterus, or fallopian tubes. For women facing these procedures, fertility preservation may be the only way to ensure the possibility of biological children in the future. Depending on the case, egg freezing, embryo freezing, or ovarian tissue freezing can be viable options.
  • Ovarian Suppression: For women who cannot delay cancer treatment for egg or embryo freezing, medications like gonadotropin-releasing hormone (GnRH) agonists may temporarily suppress ovarian function during chemotherapy. While this method does not guarantee fertility preservation, it may help protect the ovaries from the harmful effects of chemotherapy, offering another layer of potential protection.

For Young Patients: Special Considerations

For children and adolescents diagnosed with cancer, fertility preservation presents unique challenges, as they may not yet produce eggs or sperm. However, parents of young patients should still consider fertility preservation options early in the treatment process.

For prepubescent girls (young girls who have not yet begun menstruating), ovarian tissue freezing may be an option. This procedure involves removing and freezing ovarian tissue, which can potentially be reimplanted later to restore ovarian function and fertility. Although still experimental, this method has resulted in successful pregnancies in some cases.

Consultation with a Fertility Specialist

The decision to pursue fertility preservation should always involve a consultation with a fertility specialist. These specialists can guide patients through their options based on their medical condition and treatment plan. At NCCRM, our specialists work closely with oncology teams to ensure that fertility preservation is considered part of the overall cancer treatment strategy.

  • What to Expect in a Consultation: During the consultation, the fertility specialist will review the patient’s cancer diagnosis, treatment plan, and overall health. They will discuss the available fertility preservation options, including success rates, costs, and any risks involved. The patient and fertility specialist can create a tailored preservation plan that fits the patient’s timeline and medical needs.
  • Multidisciplinary Approach: Fertility preservation requires coordination between the oncology and fertility teams. By working together, these specialists can help patients make informed decisions about fertility preservation while ensuring that cancer treatment proceeds as safely and effectively as possible.

Emotional Considerations

The decision to pursue fertility preservation is not purely medical; it also involves emotional and psychological considerations. Cancer patients already face enormous stress and anxiety, and the thought of potentially losing the ability to have biological children can add another layer of emotional weight. For many patients, fertility preservation offers hope and reassurance during a difficult time, allowing them to focus on their cancer treatment without giving up their dreams of future parenthood.

  • Coping with Uncertainty: Patients may feel uncertain about their future fertility or their ability to conceive after cancer treatment. Fertility preservation provides a sense of control, offering an option for those who may not be ready to start a family now but wish to keep that possibility open in the future.
  • Support Systems: Cancer patients should have a strong support system when considering fertility preservation. This may include counseling services, support groups, or relying on family and friends during decision-making. At NCCRM, we offer counseling services and resources to help patients navigate the emotional challenges associated with cancer and fertility decisions.

 

The window of opportunity for fertility preservation can be narrow, so early action is crucial. Cancer patients, whether newly diagnosed or planning treatment, should discuss their fertility options with a specialist as soon as possible. By exploring fertility preservation methods before starting cancer treatment, patients can safeguard their future reproductive potential, giving them hope and options for family-building when they are ready. At NCCRM, we support patients in making informed, proactive decisions about their fertility health.

How NCCRM Can Help

At NCCRM (North Carolina Center for Reproductive Medicine), we understand that a cancer diagnosis can be overwhelming, especially when patients are faced with concerns about their future fertility. Our fertility specialists are here to guide cancer patients through the fertility preservation process with compassion, expertise, and personalized care. From the moment of diagnosis, we work closely with both patients and their oncology teams to ensure fertility preservation options are explored without delaying essential cancer treatments. Here’s how NCCRM can support you on this journey:

Expert Fertility Consultation

The first step in fertility preservation is a consultation with one of our experienced fertility specialists. We understand that time is of the essence, especially for cancer patients who need to begin treatment quickly. During your consultation, we will:

  • Assess Your Fertility Options: Our team will review your cancer diagnosis, treatment plan, and overall health to determine which fertility preservation options are most suitable for you. 
  • Provide a Personalized Plan: Every patient’s fertility preservation needs are unique. We work with you to create a customized plan that fits within your cancer treatment timeline, ensuring you can begin preserving fertility without unnecessary delays.
  • Coordinate with Your Oncology Team: At NCCRM, we believe in a collaborative approach to care. We will coordinate with your oncologist to ensure that fertility preservation is safely integrated into your cancer treatment plan so you can focus on both your treatment and your future family-building goals.

Comprehensive Fertility Preservation Services

NCCRM offers a range of advanced fertility preservation techniques for both men and women, including the latest technologies to give you the best chance of preserving your reproductive potential. Our services include:

  • Egg Freezing (Oocyte Cryopreservation): For women, egg freezing is one of the most effective ways to preserve fertility before starting cancer treatment. Our specialists guide patients through the entire process, from ovarian stimulation to egg retrieval and freezing.
  • Embryo Freezing: If you have a partner or wish to use donor sperm, embryo freezing is another excellent option. We assist with creating and freezing embryos that can be used for future family-building after cancer treatment.

Financial Guidance

Fertility preservation can be a significant financial concern for many cancer patients. At NCCRM, we are dedicated to making fertility preservation as accessible as possible and providing financial guidance to help you understand your options.

  • Insurance Assistance: While some insurance plans cover fertility preservation for cancer patients, others may not. Our financial advisors will help you explore your insurance coverage and understand what your plan covers.
  • Payment Plans and Financial Assistance: For patients who need financial support, we offer flexible payment plans and can provide information on financial assistance programs that may help cover the costs of fertility preservation. Our goal is to ensure that finances do not stand in the way of preserving your fertility.

Ongoing Care After Treatment

Once your cancer treatment is complete and you’re ready to start or expand your family, NCCRM will be here to support you with fertility treatments using your preserved eggs, sperm, or embryos. We will guide you through the next steps, whether you’re pursuing IVF, IUI, or another assisted reproductive technique.

Your fertility preservation journey doesn’t end with cancer treatment. As you plan for your future family, we’ll continue to be your partner, providing the fertility expertise and care you need when ready.

Sameh Toma

Dr. Sameh K. Toma, M.D.

Medical Director

Dr. Sameh K. Toma, M.D., F.A.C.O.G. is the Medical Director at the North Carolina Center for Reproductive Medicine (NCCRM), bringing over 30 years of specialized experience in reproductive medicine to patients in the Raleigh area. After earning his Bachelor of Science in Electrical Engineering from North Carolina State University, he completed his medical degree and residency at the University of North Carolina at Chapel Hill School of Medicine. 

nccrm_lead-source-tracking_script.html